Paul Tesha
Papers
1
Total Citations
12
H-Index
1
About
Dr. Paul Tesha is a leading clinical researcher in ophthalmology, with a primary focus on neovascular age-related macular degeneration (nAMD), a leading cause of blindness worldwide. His most impactful work centers on the development of stereotactic radiotherapy as a novel, non-invasive treatment for this condition. Dr. Tesha served as a key investigator on the landmark STAR trial, a pivotal, randomized, double-masked, sham-controlled device study published in 2024. This major contribution demonstrated that targeted radiation can effectively reduce the treatment burden of frequent anti-VEGF injections for nAMD patients. With 12 citations already, the STAR trial is rapidly shaping clinical practice by offering a durable, one-time alternative to lifelong injections. Dr. Tesha’s work bridges the gap between radiation oncology and retinal disease, providing a paradigm shift in managing chronic eye disease. His research is essential reading for students and clinicians interested in innovative, device-based therapies that improve patient quality of life and reduce healthcare costs.
Research Focus
Key Achievements
Top Papers
- 1